Roivant Sciences Stock (NASDAQ: ROIV) stock price, news, charts, stock research, profile.
Open | $10.66 |
Close | $10.48 |
Volume / Avg. | 2.35M / 5.46M |
Day Range | 10.45 - 10.68 |
52 Wk Range | 8.24 - 13.24 |
Market Cap | $7.89B |
P/E Ratio | 2.02 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 11.05% |
Days to Cover | 9.96 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Roivant Sciences (NASDAQ:ROIV) through any online brokerage.
Other companies in Roivant Sciences’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
There is no analysis for Roivant Sciences.
Roivant Sciences has a consensus price target of $13.27.
The stock price for Roivant Sciences (NASDAQ: ROIV) is $10.68 last updated July 3, 2024 at 1:01 PM EDT.
There are no upcoming dividends for Roivant Sciences.
Roivant Sciences’s Q1 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Roivant Sciences.
Roivant Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.